The discovery may lead to breakthrough therapies for sickle cell disease and thalassemia.

Use of hydroxyurea is bound, however, partly because not absolutely all patients react to the drug, and there are short-term and long-term undesireable effects. New therapies targeting BCL11A will be the first to straight affect the natural procedures involved with increasing HbF. WHO: Alan Michelson, M.D., Ph.D., NHLBI associate director for preliminary research, and Susan Shurin, M.D., NHLBI deputy director and performing director of the NHLBI Division of Bloodstream Diseases and Resources, are available to touch upon these results.Ambulances deployed in temporary locations can reduce response time, save lives Ambulances deployed in temporary locations which can be changed based on the time of day and accident statistics can reduce response period and may save lives on the way to the hospital. Experts at Sahlgrenska University studied fluid deployment of ambulances in Shiraz, Iran. While there is absolutely no doubt that fast commencement of treatment saves lives, Emergency Medical Providers are struggling to meet up the predesignated response period, world-wide.